Research Highlight | Published:

IMMUNOTHERAPY

Success stories

Nature Reviews Cancervolume 18page465 (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original articles

    1. Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307–312 (2018)

    2. Zacharakis, N. et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat. Med. 24, 724–730 (2018)

    Download references

    Author information

    Affiliations

    1. Nature Reviews Cancer

      • Ulrike Harjes

    Authors

    1. Search for Ulrike Harjes in:

    Corresponding author

    Correspondence to Ulrike Harjes.

    About this article

    Publication history

    Published

    DOI

    https://doi.org/10.1038/s41568-018-0039-y

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing